Sun Pharma and CMS enter into a License Agreement for Cyclosporine A and Tildrakizumab in Greater…
Under the terms of the license agreement, CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sun Pharma
Sun Pharma ties up with Samsung BioLogics
Samsung BioLogics will manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of…
Sun Pharma enters into derma segment
The company will co-promote Suncros brand across prescription and consumer channels to drive growth
Sun Pharma will focus on…
Sun Pharma announces divestment of US manufacturing units
Divests two units to Frontida BioPharm
Sun Pharma launches mobile app for asthma patients
RespiTrack seeks to enable doctors to track treatment progress of their patients and increase compliance to medication
ICGEB and Sun Pharma sign agreement to develop botanical drug to treat dengue
ICGEB will provide the technical know-how and pre-clinical expertise and Sun Pharma to develop this drug with appropriate…
Sun Pharma announces positive results of two phase-III CTs of Tildrakizumab
The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in…
ICMR, MoHFW, Govt. of Madhya Pradesh and Sun Pharma in agreement for Malaria Free India
Partnership to demonstrate malaria elimination in over 1,200 villages of MP's Mandla district by FY21
Sun Pharma receives US FDA approval for BromSite
First NSAID approved for prevention of ocular pain in patients undergoing cataract surgery
Sun Pharma enters Japanese prescription market
Acquires 14 prescription brands
Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to…